PP2A & Transcription (Keystone)

Protein phosphatase 2 (PP2 or PP2A) is a a serine/threonine phosphatase with a broad substrate specificity and diverse cellular functions. This feed focuses on the latest articles on PP2A and transcription regulation.

October 17, 2019
Review

Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy

Seminars in Cancer Biology
Vikram ShawSanjay K Srivastava
February 27, 2020
Open Access

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription

MBio
Yuki TakamatsuStephan Becker
October 28, 2019

p38-regulated FOXC1 stability is required for colorectal cancer metastasis

The Journal of Pathology
Yi ZhangHonghe Zhang
April 24, 2020
Open Access

Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer

Cell Communication and Signaling : CCS
Wei ChenMei-Jin Huang
March 19, 2020
Open Access

STRIPAK-PP2A regulates Hippo-Yorkie signaling to suppress retinal fate in the Drosophila eye disc peripodial epithelium

Journal of Cell Science
Scott J NealFrancesca Pignoni
December 12, 2019
Open Access

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

The Journal of Biological Chemistry
Caroline C FarringtonGoutham Narla
April 16, 2020
Open Access

Target of Rapamycin (TOR) Negatively Regulates Ethylene Signals in Arabidopsis

International Journal of Molecular Sciences
Fengping ZhuoMaozhi Ren
May 24, 2020
Review

Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Jerry Vriend, Mojgan Rastegar
July 28, 2020
Review
Open Access

Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Faiza NazChangyuan Yu
March 23, 2020

Mechanism of inositol-requiring enzyme 1-alpha inhibition in endoplasmic reticulum stress and apoptosis in ovarian cancer cells

Journal of Cell Communication and Signaling
Shekufe Rezghi BarezMahmoud Aghaei
August 22, 2019
Open Access

SENP2 Suppresses Necdin Expression to Promote Brown Adipocyte Differentiation

Cell Reports
Qiuli LiangJinke Cheng

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/pp2a-transcription-keystone/0365a362-b27d-43a2-8460-8365c9513679